Home / Research / Publications / Clinical biologic and immunogenic characteristics of gastroesophageal cancers GEC harboring CLDN18 ARHGAP fusions

Publications

Clinical biologic and immunogenic characteristics of gastroesophageal cancers GEC harboring CLDN18 ARHGAP fusions

Introduction

  • Claudin 18.2 (CLDN18.2) is a tight junction protein which is specifically expressed in normal stomach and GEC tissue
  • CLDN18.2 overexpression has recently emerged as a therapeutic target in advanced GEC
  • CLDN18::ARHGAP fusions are pathognomonic for GEC, but their biologic relevance in this malignancy is poorly understood
Download Publication
Learn More
Name(Required)